Capsida teams up with Lilly subsidiary for gene therapies By / On January 7, 2023 / At 2:08 am / In Chemical world 21 Views The pair will develop therapies to treat central nervous system diseases Post navigation Prev PostUS EPA proposes tighter limits on fine particulate matter air pollution Next PostDoes the periodic table reveal laws of nature? You May Also Like New Jersey sues Dow Chemical and others over 1,4-dioxane pollution On March 28, 2023 | In Chemical world Sentencing delayed again for Harvard’s former chemistry head On March 28, 2023 | In Chemical world Meeting the tigers of the lab On March 28, 2023 | In Chemical world